With key expansions coming to fruition on either side of the pond, specialist CDMO Hovione is making sure that drugmakers can ...
Addressing pressing questions about upcoming ATTR-CM competition and market opportunity, Alnylam management on Tuesday ...
Roche’s Genentech is backing this year’s Walk to End Lupus Now, taking up a sponsorship opportunity claimed by GSK in ...
New drug manufacturer Neion Bio has emerged from stealth after incubating a novel way to cook up biologic drugs. | The new ...
After becoming a prominent public face of the CDC’s revamped Advisory Committee on Immunization Practices (ACIP), physician ...
After attracting GSK with its subcutaneous delivery tech at the top of the year, South Korea’s Alteogen has snared another ...
Ionis Pharmaceuticals is dramatically lowering the price of its blockbuster hopeful Tryngolza (olezarsen) as it prepares to ...
Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
The FDA has given the all-clear to Corcept’s class-first Lifyorli (relacorilant) to treat adults with platinum-resistant ...
Novartis is facing a class-action lawsuit alleging it shared, without patients’ consent, sensitive health information it ...
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease, breaking the ...
A high-profile drug fraud case that could see the pharmaceutical industry thrown into the Racketeer Influenced and Corrupt ...
UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results